Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8497284 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients
Conditions: Cystic Fibrosis;   Rhinosinusitis;   Lung Diseases
Interventions: Drug: Tobramycin nebulized nasally;   Drug: Physiologic serum nebulized nasally
2 Completed A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Condition: Cystic Fibrosis
Intervention: Drug: tobramycin

Indicates status has not been verified in more than two years